Human adult mesenchymal stem cells improve rat spatial cognitive function after systemic hemorrhagic shock

Area of Science:

• Neuroscience
• Regenerative Medicine
• Stem Cell Biology

Background:

• Systemic hemorrhagic shock can lead to cerebral oligemia, potentially causing cognitive deficits.
• Mesenchymal stem cells (MSCs) are being investigated for their therapeutic potential in various conditions.

Purpose of the Study:

• To evaluate the protective effects of human adult mesenchymal stem cells (hMSC) on cognitive function in a rat model of systemic hemorrhagic shock.
• To assess the impact of hMSC infusion on survival rates and cerebral apoptosis following induced hypotension.

Main Methods:

• A rat model of systemic hemorrhagic shock was established, inducing hypotension and cerebral oligemia.
• Human processed lipoaspirate-derived mesenchymal stem cells (hMSC) were administered intravenously immediately after the hypotension period.
• Cognitive spatial abilities were assessed using the Morris water maze before and after the shock and hMSC treatment.
• Immunohistological analysis included BrdU staining to track cell migration and apoptosis markers.

Main Results:

• hMSC transplantation significantly improved spatial cognitive abilities in rats that experienced hypotension.
• hMSC infusion reduced mortality in the hypotension group from 50% to 25%.
• No signs of cerebral apoptosis were detected, and BrdU-labeled cells were primarily found in the spleen, not the brain, 6 days post-administration.

Conclusions:

• Human adult mesenchymal stem cells (hMSC) demonstrate protective effects on cognitive function and survival after transient cerebral oligemia.
• hMSCs derived from peripheral sources show promise for improving outcomes in conditions involving temporary brain blood supply reduction.
• Further research is needed to elucidate the specific mechanisms underlying the neuroprotective effects of hMSCs in this context.